
Dameron Levest Jones
Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615 |
| Total Applications | 2574 |
| Issued Applications | 1523 |
| Pending Applications | 392 |
| Abandoned Applications | 685 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10996391
[patent_doc_number] => 20160193337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'IRON-SALEN COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 14/990981
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5160
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990981 | Iron-salen complex | Jan 7, 2016 | Issued |
Array
(
[id] => 13714507
[patent_doc_number] => 20170368208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => CANCER IMAGING AGENT
[patent_app_type] => utility
[patent_app_number] => 15/542230
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542230 | CANCER IMAGING AGENT | Jan 7, 2016 | Abandoned |
Array
(
[id] => 11002577
[patent_doc_number] => 20160199524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING'
[patent_app_type] => utility
[patent_app_number] => 14/963648
[patent_app_country] => US
[patent_app_date] => 2015-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 62703
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14963648
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/963648 | RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING | Dec 8, 2015 | Abandoned |
Array
(
[id] => 14664943
[patent_doc_number] => 10370362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
[patent_app_type] => utility
[patent_app_number] => 14/962242
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 12667
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962242 | Pyrazine derivatives with extended conjugation and methods of using the same in optical applications | Dec 7, 2015 | Issued |
Array
(
[id] => 11002569
[patent_doc_number] => 20160199519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Multimodal Imaging of Fibrin'
[patent_app_type] => utility
[patent_app_number] => 14/954236
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16141
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/954236 | Multimodal imaging of fibrin | Nov 29, 2015 | Issued |
Array
(
[id] => 13079363
[patent_doc_number] => 10059739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Non-benzenoid aromatic systems for imaging, monitoring and therapy
[patent_app_type] => utility
[patent_app_number] => 14/950928
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31309
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 558
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14950928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/950928 | Non-benzenoid aromatic systems for imaging, monitoring and therapy | Nov 23, 2015 | Issued |
Array
(
[id] => 12246300
[patent_doc_number] => 09919065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Somatostatin analogs with inhibitory activity to growth hormone release'
[patent_app_type] => utility
[patent_app_number] => 14/949473
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18170
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949473
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/949473 | Somatostatin analogs with inhibitory activity to growth hormone release | Nov 22, 2015 | Issued |
Array
(
[id] => 10705557
[patent_doc_number] => 20160051704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'MOLECULAR IMAGING PROBES FOR LUNG CANCER INTRAOPERATIVE GUIDANCE'
[patent_app_type] => utility
[patent_app_number] => 14/937054
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 18514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937054
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/937054 | MOLECULAR IMAGING PROBES FOR LUNG CANCER INTRAOPERATIVE GUIDANCE | Nov 9, 2015 | Abandoned |
Array
(
[id] => 12057221
[patent_doc_number] => 20170333565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'TLR9 TARGETED CYTOTOXIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/522956
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8576
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522956
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522956 | TLR9 TARGETED CYTOTOXIC AGENTS | Oct 29, 2015 | Abandoned |
Array
(
[id] => 11047483
[patent_doc_number] => 20160244441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => '2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/925574
[patent_app_country] => US
[patent_app_date] => 2015-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27119
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14925574
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/925574 | 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives | Oct 27, 2015 | Issued |
Array
(
[id] => 10699481
[patent_doc_number] => 20160045626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'Methods and Compositions for Improved Labeling of Targeting Peptides'
[patent_app_type] => utility
[patent_app_number] => 14/922619
[patent_app_country] => US
[patent_app_date] => 2015-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 41924
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/922619 | Methods and Compositions for Improved Labeling of Targeting Peptides | Oct 25, 2015 | Abandoned |
Array
(
[id] => 11567289
[patent_doc_number] => 20170105933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'Suppression of Undesired 18 FDG Uptake within inflammatory lymph nodes and inflamed tissues on Positron Emission Tomography Scans that are obtained for Neoplastic Staging'
[patent_app_type] => utility
[patent_app_number] => 14/918352
[patent_app_country] => US
[patent_app_date] => 2015-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 471
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14918352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/918352 | Suppression of Undesired 18 FDG Uptake within inflammatory lymph nodes and inflamed tissues on Positron Emission Tomography Scans that are obtained for Neoplastic Staging | Oct 19, 2015 | Abandoned |
Array
(
[id] => 10676703
[patent_doc_number] => 20160022847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'Radiotracer Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/877107
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9044
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14877107
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/877107 | Radiotracer compositions | Oct 6, 2015 | Issued |
Array
(
[id] => 12000315
[patent_doc_number] => 20170304470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/511701
[patent_app_country] => US
[patent_app_date] => 2015-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20780
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 53
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511701 | Hsp9O-targeted inflammation and infection imaging and therapy | Sep 16, 2015 | Issued |
Array
(
[id] => 12000313
[patent_doc_number] => 20170304468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/512276
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3677
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512276
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512276 | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | Sep 2, 2015 | Issued |
Array
(
[id] => 11023739
[patent_doc_number] => 20160220694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Vitamin-Receptor Binding Drug Delivery Conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/836255
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836255
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/836255 | Vitamin-Receptor Binding Drug Delivery Conjugates | Aug 25, 2015 | Abandoned |
Array
(
[id] => 13154061
[patent_doc_number] => 10093743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using
[patent_app_type] => utility
[patent_app_number] => 14/835934
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 33
[patent_no_of_words] => 5915
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14835934
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/835934 | Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using | Aug 25, 2015 | Issued |
Array
(
[id] => 15895395
[patent_doc_number] => 20200147216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => DISEASE DETECTION AND TREATMENT THROUGH ACTIVATION OF COMPOUNDS USING EXTERNAL ENERGY
[patent_app_type] => utility
[patent_app_number] => 14/836169
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836169
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/836169 | DISEASE DETECTION AND TREATMENT THROUGH ACTIVATION OF COMPOUNDS USING EXTERNAL ENERGY | Aug 25, 2015 | Abandoned |
Array
(
[id] => 11820666
[patent_doc_number] => 20170209603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'COMPOSITIONS TARGETING RADIATION-INDUCED MOLECULES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/328829
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21527
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328829 | Compositions targeting radiation-induced molecules and methods of use thereof | Jul 23, 2015 | Issued |
Array
(
[id] => 12137104
[patent_doc_number] => 20180015187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/545590
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 18896
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 54
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545590 | COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME | Jul 16, 2015 | Abandoned |